252 related articles for article (PubMed ID: 18525396)
1. Effects of darbepoetin-alpha on quality of life and emotional stress in anemic patients with chronic heart failure.
Kourea K; Parissis JT; Farmakis D; Paraskevaidis I; Panou F; Filippatos G; Kremastinos DT
Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):365-9. PubMed ID: 18525396
[TBL] [Abstract][Full Text] [Related]
2. Effects of darbepoetin alpha on right and left ventricular systolic and diastolic function in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Parissis JT; Kourea K; Panou F; Farmakis D; Paraskevaidis I; Ikonomidis I; Filippatos G; Kremastinos DT
Am Heart J; 2008 Apr; 155(4):751.e1-7. PubMed ID: 18371487
[TBL] [Abstract][Full Text] [Related]
3. Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial.
Ponikowski P; Anker SD; Szachniewicz J; Okonko D; Ledwidge M; Zymlinski R; Ryan E; Wasserman SM; Baker N; Rosser D; Rosen SD; Poole-Wilson PA; Banasiak W; Coats AJ; McDonald K
J Am Coll Cardiol; 2007 Feb; 49(7):753-62. PubMed ID: 17306703
[TBL] [Abstract][Full Text] [Related]
4. Effects of darbepoetin-alpha on plasma pro-inflammatory cytokines, anti-inflammatory cytokine interleukin-10 and soluble Fas/Fas ligand system in anemic patients with chronic heart failure.
Kourea K; Parissis JT; Farmakis D; Panou F; Paraskevaidis I; Venetsanou K; Filippatos G; Kremastinos DT
Atherosclerosis; 2008 Jul; 199(1):215-21. PubMed ID: 17991471
[TBL] [Abstract][Full Text] [Related]
5. Effects of Darbepoetin Alfa on plasma mediators of oxidative and nitrosative stress in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Parissis JT; Kourea K; Andreadou I; Ikonomidis I; Markantonis S; Ioannidis K; Paraskevaidis I; Iliodromitis E; Filippatos G; Kremastinos DT
Am J Cardiol; 2009 Apr; 103(8):1134-8. PubMed ID: 19361602
[TBL] [Abstract][Full Text] [Related]
6. Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia.
van Veldhuisen DJ; Dickstein K; Cohen-Solal A; Lok DJ; Wasserman SM; Baker N; Rosser D; Cleland JG; Ponikowski P
Eur Heart J; 2007 Sep; 28(18):2208-16. PubMed ID: 17681958
[TBL] [Abstract][Full Text] [Related]
7. Effects of levosimendan on quality of life and emotional stress in advanced heart failure patients.
Parissis JT; Papadopoulos C; Nikolaou M; Bistola V; Farmakis D; Paraskevaidis I; Filippatos G; Kremastinos D
Cardiovasc Drugs Ther; 2007 Aug; 21(4):263-8. PubMed ID: 17610056
[TBL] [Abstract][Full Text] [Related]
8. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
Toblli JE; Lombraña A; Duarte P; Di Gennaro F
J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
[TBL] [Abstract][Full Text] [Related]
10. Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia.
Ghali JK; Anand IS; Abraham WT; Fonarow GC; Greenberg B; Krum H; Massie BM; Wasserman SM; Trotman ML; Sun Y; Knusel B; Armstrong P;
Circulation; 2008 Jan; 117(4):526-35. PubMed ID: 18195176
[TBL] [Abstract][Full Text] [Related]
11. Functional electrical stimulation of peripheral muscles improves endothelial function and clinical and emotional status in heart failure patients with preserved left ventricular ejection fraction.
Karavidas A; Driva M; Parissis JT; Farmakis D; Mantzaraki V; Varounis C; Paraskevaidis I; Ikonomidis I; Pirgakis V; Anastasiou-Nana M; Filippatos G
Am Heart J; 2013 Oct; 166(4):760-7. PubMed ID: 24093858
[TBL] [Abstract][Full Text] [Related]
12. Clinical and prognostic implications of self-rating depression scales and plasma B-type natriuretic peptide in hospitalised patients with chronic heart failure.
Parissis JT; Nikolaou M; Farmakis D; Bistola V; Paraskevaidis IA; Adamopoulos S; Filippatos G; Kremastinos DT
Heart; 2008 May; 94(5):585-9. PubMed ID: 17761502
[TBL] [Abstract][Full Text] [Related]
13. Assessing symptom burden using the M. D. Anderson symptom inventory in patients with chemotherapy-induced anemia: results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200 microg every 2 weeks.
Gabrilove JL; Perez EA; Tomita DK; Rossi G; Cleeland CS
Cancer; 2007 Oct; 110(7):1629-40. PubMed ID: 17694552
[TBL] [Abstract][Full Text] [Related]
14. Treating anemia in older adults with heart failure with a preserved ejection fraction with epoetin alfa: single-blind randomized clinical trial of safety and efficacy.
Maurer MS; Teruya S; Chakraborty B; Helmke S; Mancini D
Circ Heart Fail; 2013 Mar; 6(2):254-63. PubMed ID: 23258574
[TBL] [Abstract][Full Text] [Related]
15. Intravenous iron alone for the treatment of anemia in patients with chronic heart failure.
Bolger AP; Bartlett FR; Penston HS; O'Leary J; Pollock N; Kaprielian R; Chapman CM
J Am Coll Cardiol; 2006 Sep; 48(6):1225-7. PubMed ID: 16979010
[TBL] [Abstract][Full Text] [Related]
16. Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome.
Palazzuoli A; Silverberg DS; Iovine F; Calabrò A; Campagna MS; Gallotta M; Nuti R
Am Heart J; 2007 Oct; 154(4):645.e9-15. PubMed ID: 17892986
[TBL] [Abstract][Full Text] [Related]
17. Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial.
McMurray JJ; Anand IS; Diaz R; Maggioni AP; O'Connor C; Pfeffer MA; Polu KR; Solomon SD; Sun Y; Swedberg K; Tendera M; van Veldhuisen DJ; Wasserman SM; Young JB;
Eur J Heart Fail; 2009 Aug; 11(8):795-801. PubMed ID: 19633103
[TBL] [Abstract][Full Text] [Related]
18. Beta-erythropoietin effects on ventricular remodeling, left and right systolic function, pulmonary pressure, and hospitalizations in patients affected with heart failure and anemia.
Palazzuoli A; Silverberg DS; Calabrò A; Spinelli T; Quatrini I; Campagna MS; Franci B; Nuti R
J Cardiovasc Pharmacol; 2009 Jun; 53(6):462-7. PubMed ID: 19455052
[TBL] [Abstract][Full Text] [Related]
19. Relation of Longitudinal Changes in Quality of Life Assessments to Changes in Functional Capacity in Patients With Heart Failure With and Without Anemia.
Cooper TJ; Anker SD; Comin-Colet J; Filippatos G; Lainscak M; Lüscher TF; Mori C; Johnson P; Ponikowski P; Dickstein K
Am J Cardiol; 2016 May; 117(9):1482-7. PubMed ID: 27015889
[TBL] [Abstract][Full Text] [Related]
20. The Support, Education, and Research in Chronic Heart Failure Study (SEARCH): a mindfulness-based psychoeducational intervention improves depression and clinical symptoms in patients with chronic heart failure.
Sullivan MJ; Wood L; Terry J; Brantley J; Charles A; McGee V; Johnson D; Krucoff MW; Rosenberg B; Bosworth HB; Adams K; Cuffe MS
Am Heart J; 2009 Jan; 157(1):84-90. PubMed ID: 19081401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
